|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date26 Mar 1974 |
|
MechanismSodium channels blockers [+1] |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date26 Nov 1973 |
100 Clinical Results associated with Bel-Mar Laboratories Inc
0 Patents (Medical) associated with Bel-Mar Laboratories Inc
100 Deals associated with Bel-Mar Laboratories Inc
100 Translational Medicine associated with Bel-Mar Laboratories Inc